Features of Pathogenesis of Human Viral Infections and Antiviral Drugs

Among infectious diseases, viral infections are the leading cause of death worldwide, especially in the most low-income countries, particularly in young children. Most of the human viruses are all well characterized in terms of structure, life-cycle, tropism, and associated primary pathologies, but...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (84 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02564nam-a2200661z--4500
001 993545155204498
005 20231214133417.0
006 m o d
007 cr|mn|---annan
008 202105s2021 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000040695 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/68341 
035 |a (EXLCZ)995400000000040695 
041 0 |a eng 
100 1 |a Aquaro, Stefano  |4 edt 
245 1 0 |a Features of Pathogenesis of Human Viral Infections and Antiviral Drugs 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 electronic resource (84 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Among infectious diseases, viral infections are the leading cause of death worldwide, especially in the most low-income countries, particularly in young children. Most of the human viruses are all well characterized in terms of structure, life-cycle, tropism, and associated primary pathologies, but many of the pathogenetic mechanisms underlying their ability to cause acute infection, persist or reactivate in the host and cause chronic and/or degenerative damage, and still need to be fully clarified. At the same time, it seems necessary to develop novel therapeutic approaches and rationale, and possibly more potent antiviral compounds that are addressed to novel targets. 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a hRSV 
653 |a F gene 
653 |a G gene 
653 |a children 
653 |a respiratory diseases 
653 |a genotyping 
653 |a Saudi Arabia 
653 |a α chemokine receptor 4 
653 |a β-chemokine receptor 5 
653 |a human immunodeficiency virus 
653 |a monocyte-derived macrophages 
653 |a HPV 
653 |a sexually transmitted diseases (STDs) 
653 |a laboratory methods 
653 |a PCR 
653 |a genotypes 
653 |a surveillance 
653 |a epidemiology 
653 |a exopolysaccharides 
653 |a lactic acid bacteria 
653 |a human adenovirus type 5 
653 |a antiviral activity 
653 |a cell cycle 
653 |a prevalence 
653 |a hepatitis B virus 
653 |a genotype 
653 |a bahrain 
653 |a sRAGE 
653 |a oxidative stress 
653 |a inflammation 
653 |a warts 
776 |z 3-03943-917-0 
776 |z 3-03943-918-9 
700 1 |a Aquaro, Stefano  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:53:16 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337869100004498&Force_direct=true  |Z 5337869100004498  |b Available  |8 5337869100004498